FDA Unfurls Expansive Topic List To Guide Launch Of Tobacco Mission
FDA's request for comments on regulating tobacco products omits few, if any issues, likely generating substantial input to implement the agency's new authorities
More from Archive
More from HBW Insight
Now available without a prescription, Dymista Control is the first OTC combination treatment for consumers who are struggling to control their seasonal allergic rhinitis with a corticosteroid or antihistamine nasal spray, according to the firm.
Stakeholders are still waiting for the US FDA to issue its widely anticipated proposed rule to prohibit formaldehyde and formaldehyde releasers from hair smoothing or straightening products.
White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.